Cargando…

Kawasaki Disease, MIS-C and COVID-19

Detalles Bibliográficos
Autores principales:	Huang, Ying-Hsien, Kuo, Ho-Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10605357/ https://www.ncbi.nlm.nih.gov/pubmed/37892250 http://dx.doi.org/10.3390/children10101587

Ejemplares similares

Kawasaki Disease in the Time of COVID-19 and MIS-C – The International Kawasaki Disease Registry
por: Harahsheh, Ashraf S., et al.
Publicado: (2023)

Perineal Erythema in Kawasaki Disease and MIS-C
por: Sánchez-Alarcón, María Teresita, et al.
Publicado: (2021)

Innate immune response analysis in COVID-19 and kawasaki disease reveals MIS-C predictors
por: Yang, Chin-An, et al.
Publicado: (2022)

Pathophysiological and clinical point of view on Kawasaki disease and MIS-C
por: Vaňková, Lenka, et al.
Publicado: (2023)

Comparison of Laboratory Data between Children with Kawasaki Disease and COVID-19
por: Liu, Xiao-Ping, et al.
Publicado: (2022)

Kawasaki Disease and Allergic Diseases
por: Huang, Po-Yu, et al.
Publicado: (2021)

Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker
por: Huang, Ying-Hsien, et al.
Publicado: (2017)

Editorial: Kawasaki disease: an ongoing enigma tangled with the appearance of MIS-C
por: Bratincsak, Andras, et al.
Publicado: (2023)

Kawasaki disease and MIS-C share a host immune response
por: Tsoukas, Paul, et al.
Publicado: (2022)

Identifying Downregulation of Autophagy Markers in Kawasaki Disease
por: Huang, Fu-Chen, et al.
Publicado: (2020)

Immunophenotyping of peripheral blood cells allows to discriminate MIS-C and Kawasaki disease
por: Castaldo, Alice, et al.
Publicado: (2022)

Comparable bidirectional neutrophil immune dysregulation between Kawasaki disease and severe COVID-19
por: Chen, Kuang-Den, et al.
Publicado: (2022)

Desquamation in Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2021)

Expression of Eosinophilic Subtype Markers in Patients with Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2022)

Multisystem Inflammatory Syndrome in Children (MIS-C) with COVID-19: Insights from simultaneous familial Kawasaki Disease cases
por: Ebina-Shibuya, R., et al.
Publicado: (2020)

Current Understanding of Multisystem Inflammatory Syndrome (MIS-C) Following COVID-19 and Its Distinction from Kawasaki Disease
por: Bukulmez, Hulya
Publicado: (2021)

Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Parums, Dinah V.
Publicado: (2021)

Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease
por: Kuo, Ho-Chang, et al.
Publicado: (2017)

Increase expression of CD177 in Kawasaki disease
por: Huang, Ying-Hsien, et al.
Publicado: (2019)

Tight junction protein ZO-1 in Kawasaki disease
por: Lai, Wan-Tz, et al.
Publicado: (2021)

Mechanisms of Immune Dysregulation in COVID-19 Are Different From SARS and MERS: A Perspective in Context of Kawasaki Disease and MIS-C
por: Dhaliwal, Manpreet, et al.
Publicado: (2022)

Childhood multisystem inflammatory syndrome associated with COVID‐19 (MIS‐C): Distinct from Kawasaki disease or part of the same spectrum?
por: Santaniello, Maria, et al.
Publicado: (2022)

C-Reactive Protein to Albumin Ratio for Predicting Coronary Artery Lesions and Intravenous Immunoglobulin Resistance in Kawasaki Disease
por: Tsai, Chih-Min, et al.
Publicado: (2020)

The Expression of Glycoprotein Genes in the Inflammatory Process of Kawasaki Disease
por: Kuo, Kuang-Che, et al.
Publicado: (2020)

Kawasaki-like disease among Italian children in the COVID-19 era
por: Kuo, Ho-Chang
Publicado: (2020)

Basophils Predict Mite Sensitization in Patients with Kawasaki Disease
por: Chang, Ling-Sai, et al.
Publicado: (2023)

Epigenetic hypomethylation and upregulation of NLRC4 and NLRP12 in Kawasaki disease
por: Huang, Ying-Hsien, et al.
Publicado: (2018)

Epigenetic Regulation of Macrophage Marker Expression Profiles in Kawasaki Disease
por: Guo, Mindy Ming-Huey, et al.
Publicado: (2020)

COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group
por: Yilmaz Ciftdogan, Dilek, et al.
Publicado: (2022)

Public Health Interventions for COVID-19 Reduce Kawasaki Disease in Taiwan
por: Yang, Ya-Ling, et al.
Publicado: (2021)

Increased Expression of Pyroptosis in Leukocytes of Patients with Kawasaki Disease
por: Kuo, Kuang-Che, et al.
Publicado: (2021)

SARS-CoV-2–related MIS-C: A key to the viral and genetic causes of Kawasaki disease?
por: Sancho-Shimizu, Vanessa, et al.
Publicado: (2021)

Similarities and Differences between Multisystem Inflammatory Syndrome in Children (MIS-C) and Kawasaki Disease Shock Syndrome
por: Lee, Jin, et al.
Publicado: (2023)

An Artificial Intelligence-guided signature reveals the shared host immune response in MIS-C and Kawasaki disease
por: Ghosh, Pradipta, et al.
Publicado: (2022)

Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease
por: Huang, Ying-Hsien, et al.
Publicado: (2016)

Comparison of COVID-19-associated multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease shock syndrome: case reports and literature review
por: Lee, Songmi, et al.
Publicado: (2023)

CD28 Expression Distinguishes Plasma Cell Fate in Pediatric Patients Suffering from COVID-19/Kawasaki's Disease Vs MIS-C
por: Utley, Adam, et al.
Publicado: (2020)

Multisystem inflammatory syndrome in children (MIS-C) related to COVID-19 infection in the state of Qatar: Association with Kawasaki-like Illness
por: Magboul, Samar, et al.
Publicado: (2021)

Immunotherapy for MIS-C — IVIG, Glucocorticoids, and Biologics
por: DeBiasi, Roberta L.
Publicado: (2021)

Genetic Variants of CD209 Associated with Kawasaki Disease Susceptibility
por: Kuo, Ho-Chang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_drf3br2bvuhhlf7s2bbhs7fjrv